Client Results & Business Cases

Integrated two pharmaceutical companies across five countries, delivering 15% operational cost synergies and 13% revenue growth.

Optimized asset portfolio across seven sites, relocating production to Mexico, achieving 4x enterprise value growth.

Transformed manufacturing operations for energy technology leader, doubling production output while identifying $16M EBITDA opportunities.

Chemical company restructured operations post-Chapter 11, implementing organizational redesign and maintenance excellence, achieving €6M annual savings.

Harmonized post-merger manufacturing cultures through customized operating system, delivering 40% cost reduction and sustainable capabilities.

Industrial machinery manufacturer faced complexity in custom equipment production. We implemented modular design principles, standardized components, and optimized project management, reducing lead times by 40%.

Food ingredients supplier required rapid turnaround after quality issues. We stabilized operations, rebuilt quality systems, and restored customer confidence, returning to full production within 6 months.

Window manufacturer required operational turnaround amid market pressures. We restructured production, implemented lean manufacturing, and optimized supply chain, reducing costs by 30%.

Petrochemical manufacturer needed operational excellence across multiple plants. We standardized best practices, implemented digital solutions, and optimized energy usage, reducing operating costs by 15%.

Energy infrastructure operator faced aging assets and rising maintenance costs. We implemented reliability-centered maintenance, optimized turnarounds, and enhanced asset management, extending equipment life by 30%.

Agricultural producer needed productivity improvement and waste reduction. We optimized growing processes, automated harvesting operations, and enhanced quality control, increasing yield by 25%.

Investment fund required battery manufacturing joint venture assessment. We conducted technical due diligence, operational analysis, and risk evaluation, identifying 35% downside risk and 15% EBITDA upside.

Scientific instruments manufacturer faced production bottlenecks and quality challenges. We redesigned manufacturing flow, implemented lean principles, and enhanced testing protocols, improving on-time delivery to 95%.

Operational due diligence revealed 105% Capex adjustments, enabling accurate investment sizing for bakery acquisition.